Logos Global Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-700,000
| Closed | -$12.3M | – | 68 |
|
|
2024
Q1 | $12.3M | Buy |
700,000
+100,000
| +17% | +$1.75M | 0.99% | 26 |
|
|
2023
Q4 | $13.1M | Sell |
600,000
-450,000
| -43% | -$9.8M | 1.22% | 19 |
|
|
2023
Q3 | $16.1M | Sell |
1,050,000
-75,000
| -7% | -$1.15M | 2.15% | 15 |
|
|
2023
Q2 | $26.8M | Buy |
1,125,000
+175,000
| +18% | +$4.16M | 3.64% | 10 |
|
|
2023
Q1 | $24.2M | Sell |
950,000
-50,000
| -5% | -$1.27M | 3.46% | 11 |
|
|
2022
Q4 | $29.2M | Hold |
1,000,000
| – | – | 3.42% | 10 |
|
|
2022
Q3 | $20.5M | Buy |
+1,000,000
| New | +$20.5M | 2.52% | 16 |
|
|
2021
Q4 | – | Sell |
-1,500,000
| Closed | -$24.7M | – | 79 |
|
|
2021
Q3 | $24.7M | Buy |
+1,500,000
| New | +$24.7M | 1.78% | 19 |
|
|
2021
Q2 | – | Sell |
-550,000
| Closed | -$9.19M | – | 65 |
|
|
2021
Q1 | $9.19M | Hold |
550,000
| – | – | 0.9% | 24 |
|
|
2020
Q4 | $9.05M | Buy |
+550,000
| New | +$9.05M | 0.78% | 27 |
|